Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial
Official title:
The Correlation Between Blood omega3 and ADHD
Verified date | March 2015 |
Source | Ziv Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | Israel: Ministry of Health |
Study type | Interventional |
Attention deficit hyperactivity disorder (ADHD) is a major problem in children and
adolescents. Clinical and biochemical evidence suggests that deficiencies of polyunsaturated
fatty acids (PUFA) could be related to ADHD. PUFAs are the major components of brain with
important physiologically active functions.
Aim: Study the relationship between omega3 blood values and ADHD clinical status.
Methods: The investigators will recruit 30 children, who have been diagnosed with ADHD by a
child psychiatrist. In addition the investigators will recruit a control group of 30
children without ADHD and related neuropsychiatric syndromes. Blood will be taken from all
children.
The ADHD children will be asked to consume omega3 capsules for 6 month. After 3 and 6
months, all children will undergo clinical examination and blood tests will be taken for
omega3 index analysis. Blind frozen samples of isolated red blood cell (RBC) will be
analyzed according to the omega3 index methodology.
Status | Not yet recruiting |
Enrollment | 60 |
Est. completion date | April 2016 |
Est. primary completion date | September 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 6 Years to 14 Years |
Eligibility |
Inclusion Criteria: - ADHD group: Children diagnosed with ADHD aged 6-14; children who have not received a dietary supplement of omega3 in the last month Control group inclusion criteria: Children without ADHD and related neuropsychiatric syndromes aged 6-14, Children who have not received a dietary supplement of omega3 in the last month. Exclusion Criteria: - Children with severe chronic or autoimmune disorders, children who received a dietary supplement of omega3 in the last month |
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Supportive Care
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Ayelet Omer Armon |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | blood omega3 | 6 month | No | |
Secondary | ADHD Symptoms | Will be assessed using the ADHD Rating Scale IV (ADHD RS). | 6 month | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03260205 -
Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
|
Phase 3 | |
Withdrawn |
NCT03546400 -
Safety, Tolerability and PK Study of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD.
|
Phase 4 | |
Completed |
NCT02917109 -
LearningRx Cognitive Training for ADHD
|
N/A | |
Completed |
NCT02248948 -
Superiority of Omega-3 Versus Placebo on the Improvement of ADHD in Children
|
N/A | |
Recruiting |
NCT01750307 -
The Relationship of Essential Fatty Acids to Adult ADHD: The OCEAN Study (Oils and Cognitive Effects in Adult ADHD Neurodevelopment)
|
N/A | |
Recruiting |
NCT06170996 -
Internet-Assisted Behavioral Parent Training Intervention for Children With Attention Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT00735371 -
Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
|
Phase 3 | |
Withdrawn |
NCT03580005 -
A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD.
|
Phase 4 | |
Completed |
NCT02578030 -
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
|
Phase 1 | |
Completed |
NCT02574273 -
Pilot Trial of a Social Skills Group Treatment (Secret Agent Society Program)
|
N/A | |
Completed |
NCT02257216 -
Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Recruiting |
NCT04943796 -
A Study to Learn About the Occurrence of ADHD in Adults With Mental Conditions and Their Quality of Life
|
||
Recruiting |
NCT04634006 -
Home-Based tDCS in Children With ADHD: A Randomized, Sham-Controlled tDCS and fNIRS Study
|
N/A | |
Active, not recruiting |
NCT02908802 -
Probiotic Supplement as Treatment for Students With ADHD
|
N/A | |
Completed |
NCT02604407 -
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
|
Phase 3 | |
Completed |
NCT05870605 -
Drug Use Study With Intuniv® in European Countries
|
||
Terminated |
NCT03481959 -
Effectiveness of Methylphenidate Late Formula to Reduce Cannabis Use in Young Cannabis-Related Patients and Attention Deficit Disorder Hyperactivity
|
Phase 3 | |
Terminated |
NCT03638466 -
Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With Attention-Deficit/Hyperactivity Disorder
|
Phase 2 | |
Completed |
NCT03709940 -
Brain Connectivity in Attention Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT02795637 -
Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
|
Phase 1 |